BioSpace News Archive

Kurin Inc., the inventor and manufacturer of 510-cleared Kurin® blood culture collection sets, announced that the United States Patent Office allowed its patent application and has issued U.S. Patent No. 10,827,964.

Triplet Therapeutics, Inc., a biotechnology company leveraging insights from the human genetics of repeat expansion disorders, announced the appointments of Kathy Biberstein, J.D., and Stephen Webster to its board of directors.

NanoViricides, Inc. a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, has filed its quarterly report for its first quarter of financial year 2021 with the Securities and Exchange Commission.

Co-Diagnostics, Inc. announced that its Logix Smart™ ABC and its Logix Smart™ SARS-CoV-2 multiplex test for multiple targets of the SARS-CoV-2 genome have both obtained regulatory authorization to be sold as in vitro diagnostics for the diagnosis of COVID-19 in markets that accept CE-markings, and are now available for purchase from the Company’s Utah-based ISO-13485:2016 certified facility.

Lacutamab granted PRIME designation inSézary Syndrome by the European Medicines Agency

Endometrial cancer starts in the inner lining of the uterus, and the cells grow out of control. It usually affect women past menopause, and the risk increases above the age of 40.

The increasing cases of chronic anemia and the need to reduce chronic iron overload in such patients stands as the key factor boosting the global exjade market growth.

Lower respiratory tract Infections (LRTI) are infections that affect the airways (below the extent of the larynx), including the trachea and the alveolar sacs

Anesthetic gases are generally used during surgeries to keep them unconscious.

A phase II study of NBTXR3 activated by radiation and combined with pembrolizumab for patients with recurrent or metastatic head and neck squamous cell carcinoma with limited PD-L1 expression or refractory to PD-1 blockade